Home › OncoGenex's pancreatic cancer drug found ineffective in study
 

Keywords :   


OncoGenex's pancreatic cancer drug found ineffective in study

2015-09-23 20:07:41| Biotech - Topix.net

REUTERS: Drug developer OncoGenex Pharmaceuticals Inc said its experimental combination therapy for pancreatic cancer was not effective in a mid-stage study. The intravenous drug, apatorsen, when added to Celgene Corp's combination treatment of Abraxane and chemotherapy drug gemcitabine, did not show any survival benefit when compared with the Abraxane combination alone, OncoGenex said.

Tags: found study drug cancer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.07Hurricane Beryl Graphics
05.07Hurricane Beryl Forecast Discussion Number 27
05.07Hurricane Beryl Public Advisory Number 27
05.07Hurricane Beryl Wind Speed Probabilities Number 27
05.07Hurricane Beryl Forecast Advisory Number 27
05.07Tropical Depression Aletta Graphics
05.07Tropical Depression Aletta Forecast Discussion Number 4
05.07Tropical Depression Aletta Wind Speed Probabilities Number 4
More »